Keywords: تشدید حاد; Acute exacerbation; Idiopathic interstitial pneumonia; Virus detection; Short term mortality; IPF; Non-IPF interstitial lung disease; BALF; bronchoalveolar lavage fluid; CMV; cytomegalovirus; CTD; connective tissue disease; HHV; human herpes virus; HMPV;
مقالات ISI تشدید حاد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تشدید حاد; Acute exacerbation; Chronic obstructive pulmonary disease; Emergency department; Heart rate variability;
Keywords: تشدید حاد; Cystic fibrosis; Protein species; Proteomics; Laminopathies; Acute exacerbation; CFTR; Enrichment analysis;
Keywords: تشدید حاد; Periodontal disease; Asthma; Acute exacerbation; Pneumonia; Respiratory failure;
Keywords: تشدید حاد; mTOR inhibitor; Temsirolimus; Interstitial lung disease; Drug-induced pneumonia; Acute exacerbation; AaDO2; alveolar-arterial oxygen gradient; CMV; cytomegalovirus; CRP; C-reactive protein; DAD; diffuse alveolar damage; DILD; Drug-induced interstitial lun
Keywords: تشدید حاد; Enfermedad pulmonar obstructiva crónica; Exacerbación aguda; EtiologÃa infecciosa; Gammaglobulinas; Biomarcador; Pronóstico; Mortalidad; Chronic obstructive pulmonary disease; Acute exacerbation; Infectious etiology; Gamma globulins; Biomarker; Progno
Keywords: تشدید حاد; Acute exacerbation; Idiopathic pulmonary fibrosis; Pirfenidone; Recombinant human soluble thrombomodulin; Risk factors;
Keywords: تشدید حاد; Chronic obstructive pulmonary disease; Acute exacerbation; Infectious aetiology; Gamma globulins; Biomarker; Prognostic; Mortality; Enfermedad pulmonar obstructiva crónica; Exacerbación aguda; EtiologÃa infecciosa; Gammaglobulinas; Biomarcador; Pronós
Keywords: تشدید حاد; CTD; connective tissue diseases; LC; lung cancer; SLE; systemic lupus erythematosus; PM/DM; polymyositis/dermatomyositis; SSc; systemic sclerosis; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; PS; performance
Keywords: تشدید حاد; SCLC; small cell lung cancer; ILD; interstitial lung disease; NSCLC; non-small cell lung cancer; TTF-1; thyroid transcription factor-1; UIP; usual interstitial pneumonia; AE; acute exacerbation; PFS; progression-free survival; OS; overall survival; PS; pe
Keywords: تشدید حاد; acute exacerbation; asthma; cost; health care utilization; severity;
Keywords: تشدید حاد; Idiopathic pulmonary fibrosis; Acute exacerbation; Hypersensitivity pneumonitis; Connective tissue disease; Interstitial lung disease;
Keywords: تشدید حاد; Acute exacerbation; Anti-inflammatory drugs; Childhood asthma; Guideline; Long-term management;
Keywords: تشدید حاد; Asthma; COPD; Acute exacerbation; ACOS; Hospital medicine; Hospitalized patients;
Keywords: تشدید حاد; Procalcitonin; Chronic obstructive pulmonary disease; Antibiotics; Acute exacerbation
Keywords: تشدید حاد; AE; acute exacerbation; HRCT; high-resolution computed tomography; IPF; idiopathic pulmonary fibrosis; JACS; Japanese Association for Chest Surgeons; POD(s); postoperative day(s); PPT; perioperative pirfenidone treatment; UIP; usual interstitial pneumonia
Keywords: تشدید حاد; Chronic obstructive pulmonary disease; Acute exacerbation; Glucocorticoid; Meta-analysis;
Keywords: تشدید حاد; Systemic sclerosis; Interstitial lung disease; Computed tomography; Immunosuppressant; Acute exacerbation;
Keywords: تشدید حاد; AE; acute exacerbation; ATS/ERS/JRS/ALAT; American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association; FVC; forced vital capacity; HRCT; high-resolution computed tomography; IIP; idiopathic inter
Keywords: تشدید حاد; AE; acute exacerbation; CPFE; combined pulmonary fibrosis and emphysema; CPI; composite physiologic index; Dlco; diffusing capacity of the lung for carbon monoxide; HR; hazard ratio; HRCT; high-resolution CT; IPF; idiopathic pulmonary fibrosis; LC; lung c
Keywords: تشدید حاد; AE; acute exacerbation; APACHE; Acute Physiology and Chronic Health Evaluation; BALF; BAL fluid; CRP; C-reactive protein; IPF; idiopathic pulmonary fibrosis; KL-6; Krebs von der Lungen-6; LDH; lactate dehydrogenase; LMWH; low-molecularweight heparin; NIV;
Keywords: تشدید حاد; 10; 10.4; AE; acute exacerbation; CI; confidence interval; CT; computed tomography; DLCO; carbon monoxide diffusing capacity; FEV1; forced expiratory volume in 1 second; FVC; forced vital capacity; ILD; interstitial lung disease; IPF; idiopathic pulmonary
Keywords: تشدید حاد; Asthma; fibrocytes; chemokines; chemokine receptors; S100A9; AE; Acute exacerbation; Asthma AE group; Asthmatic patients during an acute exacerbation; Asthma NPF group; Asthmatic patients with normal pulmonary function; CFSE; Carboxyfluorescein succinimid
Keywords: تشدید حاد; Computed tomography (CT); Interstitial pneumonia; Acute exacerbation; Pulmonary hypertension
Keywords: تشدید حاد; Acute exacerbation; Airspace enlargement with fibrosis; Smoking-related interstitial lung disease
Keywords: تشدید حاد; Combined pulmonary fibrosis and emphysema; Lung cancer; Idiopathic interstitial pneumonias; Acute exacerbation; Chemotherapy; Emphysema; Interstitial lung disease;
Keywords: تشدید حاد; 10.4; 41.2; 41.4; AE; acute exacerbation; ALI; acute lung injury; ARDS; acute respiratory distress syndrome; CI; confidence interval; CRP; C-reactive protein; CT; computed tomography; DLCO; diffusing capacity for carbon monoxide; FEV1; forced expiratory v
Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema
Keywords: تشدید حاد; Idiopathic pulmonary fibrosis; Acute exacerbation; AE-IPF; Triggered AE; Aspergillus infection; AE; acute exacerbation; AMPH-B; amphotericin-B; CRP; C-reactive protein; CT; computed tomography; ILD; interstitial lung disease; IPF; idiopathic pulmonary fib
Treatment Rationale and Design for J-SONIC: AÂ Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis
Keywords: تشدید حاد; Acute exacerbation; Chemotherapy; IPF; NSCLC; Prospective study;
High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations
Keywords: تشدید حاد; Cytokines; Idiopathic pulmonary fibrosis; Acute exacerbation;
Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B
Keywords: تشدید حاد; Acute exacerbation; Chronic hepatitis B; Entecavir; Lamivudine; Tenofovir;
Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis
Keywords: تشدید حاد; Idiopathic pulmonary fibrosis; Acute exacerbation; Acute respiratory deterioration; Hospitalization; Mortality; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; ARD; acute respiratory deterioration; ILD; interstitial lung disease; BAL; bronchoa
ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease
Keywords: تشدید حاد; ILD; interstitial lung disease; NSCLC; non-small cell lung cancer; AE; acute exacerbation; IPF; idiopathic pulmonary fibrosis; %FVC; percent predicted forced vital capacity; %DLCO; percent predicted diffusion capacity of lung for carbon monoxide; TKI; tyr
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
Keywords: تشدید حاد; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;
The cumulative effect of air pollutants on the acute exacerbation of COPD in Shanghai, China
Keywords: تشدید حاد; Chronic obstructive pulmonary disease; Acute exacerbation; PM2.5; Cumulative effect; Seasonal variation;
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study
Keywords: تشدید حاد; Recombinant human soluble thrombomodulin; Acute exacerbation; Idiopathic pulmonary fibrosis;; 3-month survival;
Severe idiopathic pulmonary fibrosis: A clinical approach
Keywords: تشدید حاد; IPF; idiopathic pulmonary fibrosis; UIP; Usual Interstitial Pneumonia; FVC; Forced Vital Capacity; SVC; Slow Vital Capacity; FEV1; Forced Expiratory Volume in the first second; TLC; Total Lung Capacity; RV; Residual Volume; DLCO; Diffusing Capacity of the
Ability of using different dry powder inhalers during COPD exacerbations
Keywords: تشدید حاد; Chronic obstructive pulmonary disease; Acute exacerbation; Hospital admission; Inspiratory flow; Dry powder inhalers;
Direct hemoperfusion with polymyxin B-immobilized fiber for the treatment of the acute exacerbation of idiopathic pulmonary fibrosis in patients requiring invasive mechanical ventilation
Keywords: تشدید حاد; AE-IPF; acute exacerbation of idiopathic pulmonary fibrosis; ALAT; Latin American Thoracic Association; ATS; American Thoracic Society; BAL; bronchoalveolar lavage; CT; computed tomography; ERS; European Respiratory Society; FVC; forced vital capacity; IP
Value of blood eosinophilia in phenotype-directed corticosteroid therapy of COPD exacerbation: Final results
Keywords: تشدید حاد; COPD; Acute exacerbation; Exacerbation phenotype; Blood eosinophilia; Systemic steroid;
Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease
Keywords: تشدید حاد; Interstitial lung disease; D-dimer; Acute exacerbation;
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1
Keywords: تشدید حاد; LC; lung cancer; ILD; interstitial lung disease; HRCT; high-resolution computed tomography; AE; acute exacerbation; DAD; diffuse alveolar damage; IPF; idiopathic pulmonary fibrosis; PS; performance status; ECOG; Eastern Cooperative Oncology Group; NSCLC;
Validation d'un questionnaire d'évaluation de l'exacerbation dans la BPCOÂ : l'Exascore
Keywords: تشدید حاد; BPCO; Questionnaire; Validation; Exacerbation; Plan d'action; COPD; Questionnaire; Validation; Acute exacerbation; Management;
Value of the DECAF score in predicting hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease admitted to Zagazig University Hospitals, Egypt
Keywords: تشدید حاد; DECAF; APACHE II; CAPS; CURB-65; Acute exacerbation; COPD
The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis
Keywords: تشدید حاد; Hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Krebs von den Lungen-6; Surfactant protein D; Acute exacerbation; AE; acute exacerbation; ATS; American thoracic society; BAL; bronchoalveolar lavage; CRP; C-reactive protein; CVD-IP; interstiti
Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis
Keywords: تشدید حاد; d-ROMs test; Acute exacerbation; Serum biomarker; Lung function;
The value of serum procalcitonin among exacerbated COPD patients
Keywords: تشدید حاد; Procalcitonin; COPD; Acute exacerbation; Mechanical ventilation
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis – Extended analysis of pirfenidone trial in Japan
Keywords: تشدید حاد; Idiopathic pulmonary fibrosis (IPF); Acute exacerbation; Absolute decline in VC; Relative decline in VC; Risk factor
Original ResearchDiffuse Lung DiseaseThe Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): Diagnostic and Adjudication Processes
Keywords: تشدید حاد; AC; adjudication committee; ACE-IPF; Anticoagulant Effectiveness in Idiopathic Pulmonary Fibrosis; AEx; acute exacerbation; ASCEND; Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis; HRCT; high-resolution CT; IPF; i
Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy
Keywords: تشدید حاد; Clinical trials; Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone; Therapy; Treatment; AE; acute exacerbation; AEC; alveolar epithelial cell; ANCOVA; analysis of covariance; DLCO; diffusing capacity of the lung for carbon monoxide; DPLD; diffuse par